Zanubrutinib
(Update) Acalabrutinib in CLL and MCL
Obinutuzumab
Update Venetoclax in CLL
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
NCCN Guidelines for Patients
Patient Power
ASCO: COVID-19 Medical Resources